Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis-Reference-Cited by-同舟云学术

Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis

Published:2023-10-13 Issue:12 Volume:58 Page:1198-1210
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Naganuma Makoto^ORCID,Kobayashi Taku,Kunisaki Reiko,Matsuoka Katsuyoshi,Yamamoto Shojiro,Kawamoto Ami,Saito Daisuke,Nanki Kosaku,Narimatsu Kazuyuki,Shiga Hisashi,Esaki Motohiro,Yoshioka Shinichiro,Kato Shingo,Saruta Masayuki,Tanaka Shinji,Yasutomi Eriko,Yokoyama Kaoru,Moriya Kei,Tsuzuki Yoshikazu,Ooi Makoto,Fujiya Mikihiro,Nakazawa Atsushi,Abe Takayuki,Hisamatsu Tadakazu,Ogawa Souichiro,Tamura Hotaka,Uchida Keisuke,Fukui Toshiro,Fukata Norimasa,Nagahori Masakazu,Okamoto Ryuichi,Miura Miki,Yoshimatsu Yusuke,Hokari Ryota,Kakuta Yoichi,Fukuda Tomohiro,Hojyo Aya,Sagami Shintaro,Hibi Toshufumi,Sakata Yasuhisa,Tsuruta Kozo,Morita Masaru,Mitsuyama Keiichi,Shibuya Naoki,Miyazaki Ryosuke,Hayashi Ryohei,Hiraoka Sakiko,Kobayashi Kiyonori,Kajiwara Mariko,Takagi Tomohisa,Imaeda Hiroyuki,Tokunaga Eri,Ooi Mitsuru,Ueno Nobuhiro,Tahara Toshiyuki,Yokoyama Ayumu,Murasugi Shun,Kuriyama Tomoko,Ohmori Teppei,Takeuchi Ken,Hashimoto Shinichi,Hirayama Daisuke,Kazama Tomoe,Nakase Hiroshi,Miyazaki Takako,Nakamura Shiro,Oka Akihiko,Kawashima Kohsaku,Ishihara Shunji,Yanai Shunichi,Matsumoto Takayuki,Sato Toshiyuki,Yokoyama Yoko,Watanabe Kenji,Yamamoto Yasunori,Hiasa Yoichi,Bamba Hideki,Ando Akira,Ohta Yuki,Kanayama Kengo,Kato Jun,Ohmiya Naoki,Nanjyo Sohachi,

Funder

he Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00535-023-02048-w.pdf

Reference34 articles.

1. Naganuma M, Mizuno S, Nanki K, Sugimoto S, Kanai T. Recent trends and future directions for the medical treatment of ulcerative colitis. Clin J Gastroenterol. 2016;9:329–36.

2. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462–76.

3. Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142:257–65.